Table 3 Virologic, Biochemical Variables of Patients at 24 weeks After Treatment
Variable | CIFN group (n = 72) | IFN-alpha group (n = 70) |
|---|---|---|
ALT normalization, n (%) | 38 (52.8) | 37 (52.9) |
Loss of HBV-DNA, n (%) | 17 (23.6) | 14 (20.0) |
HBeAg/anti-HBe seroconversion, n (%) | 12 (16.7) | 12 (17.1) |
Loss of HbeAg, n (%) | 11 (15.3) | 10 (14.3) |
Complete response, n (%) | 5 (6.9) | 5 (7.1) |
Partial response, n (%) | 27 (37.5) | 24 (34.3) |